Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CV Sciences, Inc. (CVSI : OTC)

• Company Description    CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products. It operates primarily in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is based in Las Vegas, United States. Number of Employees: 49

• Price / Volume Information    Yesterday's Closing Price: $0.03 Daily Weekly Monthly 20 Day Moving Average: 146,156 shares Shares Outstanding: 184.79 (millions) Market Capitalization: $6.12 (millions) Beta: 0.63 52 Week High: $0.05 52 Week Low: $0.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -24.77% -26.74% 12 Week -13.80% -17.38% Year To Date -2.07% -14.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9530 Padgett Street Suite 107 - San Diego,CA 92126 USA ph: 866-290-2157 fax: 619-876-4321 ir@cvsciences.com http://www.cvsciences.com

• General Corporate Information    Officers Joseph D. Dowling - Chief Executive Officer and Director Joerg Grasser - Chief Financial Officer Jamie Corroon - Director Bill McCorkle - Director Beth Altman - Director Peer Information CV Sciences, Inc. (GSAC) CV Sciences, Inc. (CASI) CV Sciences, Inc. (ALCD.) CV Sciences, Inc. (OMNN) CV Sciences, Inc. (CGPI.) CV Sciences, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 126654102 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 184.79 Most Recent Split Date: (:1) Beta: 0.63 Market Capitalization: $6.12 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.41 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -8.45% vs. Previous Quarter: 0.39% ROE 09/30/25 - - 06/30/25 - -80.82 03/31/25 - -89.43 ROA 09/30/25 - - 06/30/25 - -19.38 03/31/25 - -22.75 Current Ratio 09/30/25 - - 06/30/25 - 1.04 03/31/25 - 1.14 Quick Ratio 09/30/25 - - 06/30/25 - 0.30 03/31/25 - 0.30 Operating Margin 09/30/25 - - 06/30/25 - -10.36 03/31/25 - -12.25 Net Margin 09/30/25 - - 06/30/25 - -10.36 03/31/25 - -12.25 Pre-Tax Margin 09/30/25 - - 06/30/25 - -10.41 03/31/25 - -12.29 Book Value 09/30/25 - - 06/30/25 - 0.01 03/31/25 - 0.01 Inventory Turnover 09/30/25 - - 06/30/25 - 1.73 03/31/25 - 1.71 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.12 03/31/25 - 0.26 Debt-to-Capital 09/30/25 - - 06/30/25 - 10.34 03/31/25 - 20.84

Powered by Zacks Investment Research ©